Results for tag: "Inclusion Body Myositis Drug"

Inclusion Body Myositis (IBM) is a rare, progressive muscle disorder that affects the muscles of the arms, legs, and trunk. It is caused by an autoimmune response, in which the body’s own immune system attacks and destroys muscle fibers. Treatment for IBM is limited, and there is currently no cure. However, there are a number of drugs available to help manage the symptoms of IBM. These drugs are typically immunosuppressants, which help to reduce the body’s immune response and slow the progression of the disease. Other drugs, such as corticosteroids, may also be used to reduce inflammation and pain. The Inclusion Body Myositis Drug market is a specialized segment of the Immune Disorders Drugs market. It is composed of a range of drugs used to treat IBM, including immunosuppressants, corticosteroids, and other medications. Companies in this market include AbbVie, Pfizer, Novartis, and Sanofi. Show Less Read more